Trending...
- Tacoma: Applicants Sought for the Human Services Commission
- NUSACC Supports Iraq Higher Education Roadshow to the United States
- Connecta Satellite Solutions Ready to Support Emergency Communications Following the Venezuela Earthquake
SEATTLE, May 14, 2021 /PRNewswire/ -- Case No 16-2-29568-1 SEA involved a handyman living a very peaceful, simple life. He was not wealthy by any means, but he loved his work and life was good. That was until one day while waiting at a stoplight, a vehicle struck him from behind at approximately 45 MPH, changing his life forever. His new normal included not being able to work, $70,000 in medical bills, struggling daily with chronic pain, the mental anguish of no one believing him, and learning the hard way just how poor his insurance coverage was. To further exacerbate his predicament, his injuries and pain were not corroborated with X-Rays, MRI's, CT Scans or Range of Motion.
His doctor, frustrated with the lack of findings, did some research and discovered MyoVision's DynaROM Motion EMG (a diagnostic tool that can prove the presence or absence of soft tissue injury) was being used by South Korean Orthopedic Surgeons to document soft tissue injury. The DynaROM was also published in the AMA's guidebook "A Practical Guide to Range of Motion Assessment," with the author referring to it as the "new gold standard" as it was more sensitive to soft tissue injury than ROM alone. The DynaROM simultaneously measures range of motion and the muscle response during motion giving it the ability to document muscle guarding (the body's natural response to pain). So the handyman's doctor ordered a DynaROM test and what happened next made history. The jury awarded $958K; one of the largest soft tissue injury awards in history.
More on Washingtoner
The handyman described the DynaROM as, "The missing puzzle piece that validated my pain. The jury understood the simple graphics that proved the insurance defense wrong. The DynaROM was essential to obtaining the award, and I am forever grateful that it has allowed me to continue care and the work I love, but at a pace which does not leave me in constant pain."
About the MyoVision SERIES-5 DynaROM
Developed under a prestigious NIH Grant, the new SERIES-5 is the result of thousands of hours of R&D and clinical application in the healthcare arena. MyoVision has been manufacturing medical equipment in the US for the past 30 years. For more information, visit myovision.com or email [email protected]
SOURCE MyoVision
Related Links
https://www.myovision.com/
His doctor, frustrated with the lack of findings, did some research and discovered MyoVision's DynaROM Motion EMG (a diagnostic tool that can prove the presence or absence of soft tissue injury) was being used by South Korean Orthopedic Surgeons to document soft tissue injury. The DynaROM was also published in the AMA's guidebook "A Practical Guide to Range of Motion Assessment," with the author referring to it as the "new gold standard" as it was more sensitive to soft tissue injury than ROM alone. The DynaROM simultaneously measures range of motion and the muscle response during motion giving it the ability to document muscle guarding (the body's natural response to pain). So the handyman's doctor ordered a DynaROM test and what happened next made history. The jury awarded $958K; one of the largest soft tissue injury awards in history.
More on Washingtoner
- Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
- Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers
- Webinar Announcement: Built for Trust: Latitude's 0 to 1 Compliance Playbook for Modern Cross-Border Payments
- OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
- Dentists launch independent platform to help practices choose the right technology
The handyman described the DynaROM as, "The missing puzzle piece that validated my pain. The jury understood the simple graphics that proved the insurance defense wrong. The DynaROM was essential to obtaining the award, and I am forever grateful that it has allowed me to continue care and the work I love, but at a pace which does not leave me in constant pain."
About the MyoVision SERIES-5 DynaROM
Developed under a prestigious NIH Grant, the new SERIES-5 is the result of thousands of hours of R&D and clinical application in the healthcare arena. MyoVision has been manufacturing medical equipment in the US for the past 30 years. For more information, visit myovision.com or email [email protected]
SOURCE MyoVision
Related Links
https://www.myovision.com/
0 Comments
Latest on Washingtoner
- 80 Arts, Culture, Heritage, and Science Organizations Funded by Tacoma Creates for 2026-2027
- Deputy Mayor Joe Bushnell Presents Tacoma Minimum Wage Community and Stakeholder Engagement Report to Economic Development Committee
- Spokane: America's 250th Celebrated in Riverfront Park with Incredible Lineup
- Spokane: City Details Fourth of July Activities, Closures
- Former MP Shri GV Harsha Kumar Meets AICC President Mallikarjun Kharge
- Tacoma: System Development Charges for Wastewater and Stormwater Utilities to Take Effect on July 1
- Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
- IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
- Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
- America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street
- Data Tiles Introduces the Decision-Driven Enterprise to North America
- Disruptor Creations Pioneers New MicroAdventure Series with TravelSpike
- Spokane City Fire Marshal Issues Outdoor Recreational Fire Restriction
- eCopier Solutions Surpasses 3,000 Five-Star Google Reviews and Maintains Perfect Five-Star Rating
- Creative Investment Research Welcomes Supreme Court Decision Protecting Federal Reserve Independence While Calling for Continued Accountability
- Ascent Solar Technologies (N A S D A Q: ASTI): Positioned at the Intersection of the New Space Economy, Defense Innovation and Next-Generation Energy
- Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Morrisville & Cary Education Centers Honored with National Award
- AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
- Henri-Lloyd Launches Sail Free to Break Down Barriers to Sailing